Cancer Cell: "Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy." A longitudinal pan-cancer single-cell atlas of ICI treatment: 441 samples, 241 patients, 10 cancer types, 1.48M TIME cells.#PanCancerAnalysis#GeneSignature#Immunotherapy